Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)

Start date: Oct 1, 2013, End date: Mar 31, 2020,

Traumatic Brain Injury (TBI) is a major cause of death and disability, leading to great personal suffering to victim and relatives, as well as huge direct and indirect costs to society. Strong ethical, medical, social and health economic reasons therefore exist for improving treatment. The CENTER-TBI project will collect a prospective, contemporary, highly granular, observational dataset of 5400 p ...
Read Project

 44

 FINISHED 

Translating neuroimaging findings from research into clinical practice (PSYSCAN)

Start date: Feb 1, 2014, End date: Jan 31, 2020,

Abstract 9Neuroimaging (NI) has enormous potential to improve the clinical care of patients with psychiatric disorders, but has yet to deliver. The PSYSCAN project will address this issue directly by developing a NI-based tool that will help clinicians resolve key clinical issues in the management of patients with psychotic disorders. Clinicians will use the tool to assess patients with a standard ...
Read Project

 24

 FINISHED 

Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies (SPRINTT)

Start date: Jul 1, 2014, End date: Jun 30, 2019,

The current healthcare systems are built around the traditional paradigm of patients suffering from a single acute illness. They are therefore largely unprepared to face the increasing demands for health services arising from the expansion of an older population with specific medical needs related to multiple chronic disorders. As a consequence, the medical conditions of a large and growing seg ...
Read Project

 27

 FINISHED 

A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer (GANNET53)

Start date: Oct 1, 2013, End date: Mar 31, 2019,

"Epithelial ovarian cancer (EOC) is the most lethal gyncaecological malignancy causing 41900 deaths annually in Europe. The predominance of aggressive Type II tumours, which are characterised by a high frequency of p53 mutations, and primary or acquired resistance to platinum-based chemotherapy profoundly contribute to the high mortality rate. With current standard therapy the median overall survi ...
Read Project

 20

 FINISHED 

The Molecular Anatomy of Neurons (NeuroMolAnatomy)

Start date: Apr 1, 2014, End date: Mar 31, 2019,

The brain is nowadays the object of a number of extensive systematic studies that focus on seemingly all aspects of its morphology and function, from overall brain architecture to neuronal connections, neuronal morphology and gene expression. However, at least one basic aspect is as yet incompletely studied: the molecular anatomy of the neuron, i.e., the copy numbers and the spatial arrangement of ...
Read Project

 1

 FINISHED 

Mitochondrial translational regulation coupled to respiratory chain assembly and protein import (MITRAC)

Start date: Feb 1, 2014, End date: Jan 31, 2019,

"Mitochondrial respiratory chain complexes assemble from nuclear- and mitochondria-encoded subunits in the inner membrane. To protect cells from accumulating unassembled subunits in the membrane, ROS generation, or damage of mitochondrial integrity, regulatory mechanisms to balance and control the fidelity of the assembly process have evolved, encorporating a retention system enabling the preserva ...
Read Project

 1

 FINISHED 

"Mitochondria, Peroxisomes and Lysosomes - the ""menage a trois"" of cellular metabolism" (MITOPEXLYSONETWORK)

Start date: Feb 1, 2014, End date: Jan 31, 2019,

The metabolic roles of mitochondria, peroxisomes and lysosomes are well established. Numerous genetic defects affecting the function of these organelles result in a wide spectrum of metabolic diseases. The involvement of these organelles in signalling pathways is receiving increasing attention. Furthermore, interactions between them and other cellular components have been elucidated. Evidence is n ...
Read Project

 1

 FINISHED 

Fine Tuning the Final Common Pathway: Molecular Determinants of Motor Unit Development and Plasticity (MU TUNING)

Start date: Nov 1, 2012, End date: Oct 31, 2017,

Motor neurons (MNs) constitute the final common pathway in the generation of behaviors by linking the CNS with the movement apparatus. Herein, MNs diversify into fast, intermediate and slow types whose properties are tuned to the speed, force and endurance of the muscle fiber contractions they elicit. The MN-muscle fiber units display marked plasticity towards chronically altered physical activity ...
Read Project

 1

 FINISHED 

The biogenesis of tail-anchored membrane proteins: knowledge and exploitation (TAMPTING)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

Even in the simplest cells, the integration of proteins into a biological membrane is a complex process that is frequently coupled to ribosomal protein synthesis, and requires the coordinated actions of several additional cellular machines. The de novo recapitulation of such a complex process is well beyond the scope of our current technical abilities. Indeed, the techniques that are used to creat ...
Read Project

 8

 FINISHED 

Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope (EU-CERT-ICD)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylactic treatment with an implantable cardioverter-defibrillator (ICD). ICD implantations have dramatically increased in recent years leading to multi-billion Euros of costs with significant regional disparities across Europe. Information on risks, benefits and cos ...
Read Project

 27

 FINISHED 

Molecular Mechanisms of Fungal Pathogen Host Interactions (ImResFun)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

ImResFun shall provide state-of-the-art training in infectious disease research and medical immunology targeting the most common human fungal pathogens, the opportunistic Candida species. The key objectives of ImResFun are: (i) to understand how immune cells and infected organs respond to invasion by Candida spp, (ii) to decipher host-defense mechanisms mediating pathogen elimination, and (iii) to ...
Read Project

 12

 FINISHED 

Innovative methodology for small populations research (InSPiRe)

Start date: Feb 1, 2014, End date: May 31, 2017,

The HEALTH.2013.4.2-3 call identifies a need for new or improved statistical methodology for clinical trials for the efficient assessment of safety and/or efficacy of treatment for small population groups. This project brings together international experts in innovative clinical trial design methodology in these specific areas along with key stakeholders including regulatory authorities, industry ...
Read Project

 9

 FINISHED 

Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) (DSD-LIFE)

Start date: Oct 1, 2012, End date: Mar 31, 2017,

Disorders of sex development (DSD) are a conglomerate of rare diseases with an estimated incidence of 1: 4500. The causes of DSD are mainly disorders with gonadal dysgenesis, decreased androgen synthesis or function in XY males or disorders with elevated androgen production in XX females. Decision on sex of rearing is difficult in some cases as the prenatal androgen imbalances result in ambiguous ...
Read Project

 17

 FINISHED 

Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies (CELLEUROPE)

Start date: Oct 1, 2012, End date: Sep 30, 2016,

Novel transplant regimens are currently being developed to improve beneficial GvL effects and reduce GvHD and infections via several new forms of cellular therapies. This newly emerging supra-disciplinary field of cellular therapy and regenerative medicine is also being used to improve outcomes in autoimmune disease (such as Rheumatoid Arthritis) and cancers. The goal of this research programme is ...
Read Project

 13

 FINISHED 

DECODING THE NEURAL CODE OF HUMAN MOVEMENTS FOR A NEW GENERATION OF MAN-MACHINE INTERFACES (DEMOVE)

Start date: Jul 1, 2011, End date: Jun 30, 2016,

"The generation of a movement is the combination of discrete events (action potentials) generated in the brain, spinal cord, nerves, and muscles. These discrete events are the result of ion exchanges across membranes, electrochemical mechanisms, and active ion pumping through energy expenditure. The ensemble of spike trains discharged in the various parts of the neuromuscular system constitutes th ...
Read Project

 1

 FINISHED 

Disc-shaped point-of-care platform for infectious disease diagnosis (DiscoGnosis)

Start date: Nov 1, 2012, End date: Apr 30, 2016,

The project aims to develop a fully integrated, automated and user-friendly platform for infectious disease diagnosis. Malaria can be treated in just 48 hours, but delayed or false diagnosis or missing a relevant alternative cause of fever may be lethal. Therefore, other diseases with similar clinical symptoms will be investigated too. DiscoGnosis will integrate micro, nano, and bio components int ...
Read Project

 8

 FINISHED 

MYOELECTRIC INTERFACING WITH SENSORY-MOTOR INTEGRATION (MYOSENS)

Start date: Apr 1, 2012, End date: Mar 31, 2016,

"Biological signals recorded from the human body can be translated into actions of external devices to create man-machine interaction. This concept has clinical implications in rehabilitation technologies for replacing or recovering impaired motor functions. Among the possible biosignals for man-machine interaction (brain, nerve, and muscle signals), muscle signals, i.e. electromyography (EMG), ar ...
Read Project

 5

 FINISHED 

VISUAL MODELLING USING GANGLION CELLS (VISUALISE)

Start date: Apr 1, 2013, End date: Mar 31, 2016,

The processing capabilities of biological visual systems are still vastly superior in terms of performance for real-time and low-power applications compared with conventional artificial vision. There is increasing evidence that biology has evolved a multitude of cell types, including at the level of the retina, to adapt to an extensive set of dynamic visual environments. Existing bio-inspired arti ...
Read Project

 5

 FINISHED 

Modulation of synaptic plasticity and circuit function by regulation of neurotrophin exocytosis (SYT ACTIVITY)

Start date: Apr 1, 2011, End date: Mar 31, 2016,

A fundamental question in neuroscience is how individual synapses and neurons act in concert to create functional circuits. While the basic mechanisms of synaptic transmission between neurons are well understood, much less is known about how individual synapses, neurons, and circuits dynamically adjust their transmission properties in response to perturbations in network activity. During the past ...
Read Project

 1

 FINISHED 

Novel biomimetic strategy for bone regeneration (INNOVABONE)

Start date: Nov 1, 2011, End date: Oct 31, 2015,

The importance of developing novel approaches for bone repair is underscored by the heavy burden on health care costs and patient suffering caused by traumatic, osteoporotic and osteolytic metastatic bone lesions. To address these health challenges, we will develop optimally performing bioinspired biomaterials mimicking the natural physiological processes underlying bone repair. Our overall approa ...
Read Project

 14

 FINISHED 

Joint European and South African Research Network in Anxiety Disorders (EUSARNAD)

Start date: Oct 1, 2011, End date: Sep 30, 2015,

The overall aim of our proposal is to build on the strengths of an existing European network for research into causes and maintaining factors in anxiety disorders and to extend these by establishing firmer research collaboration with the University of Cape Town in South Africa.Through establishing this research exchange, we aim to share knowledge and expertise among participating centres, and ensu ...
Read Project

 13

 FINISHED 

A portable device for Early detection and treatment of Traumatic Brain Injury based on advanced qEEG and HD-TES to prevent major Health problems and specially for use in emergencies and telemedicine (EMEREEG)

Start date: Oct 1, 2013, End date: Sep 30, 2015,

Traumatic Brain Injury (TBI) is recognized as a major public health concern, especially for teenagers and young adults, since it can lead to significant disruption in education, working ability, and quality-of-life in general. It is one of the leading causes of death and disability worldwide. 1.2 million EU citizens are hospitalized with TBI each year and of which 50.000 die. The total economic bu ...
Read Project

 8

 FINISHED 

Nanosystems for the early Diagnosis of Neurodegenerative diseases (NADINE)

Start date: Sep 1, 2010, End date: Aug 31, 2015,

Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multimodal “metabiomarker” signatures. Progress, however, is hindered by low abundance of many biomarkers of interest in body fluids, in absolute concentration and with regard to other biomolecules. The aim of the present project is to apply these progresses in bio ...
Read Project

 19

 FINISHED 

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia (NEUROSIS)

Start date: Mar 1, 2009, End date: Aug 31, 2015,

HYPOTHESIS: Early inhalation of Budesonide (BS) reduces the absolute risk of developing bronchopulmonary dysplasia (BPD) or death in preterm infants born between 23 and 27 weeks gestational age (GA) by 10%. PRIMARY OBJECTIVE: Survival without BPD at 36 weeks GA. SECONDARY OBJECTIVES: (1) neurodevelopment at a corrected age of 18-22 months; (2) adverse treatment effects; (3) mortality at 36 weeks G ...
Read Project

 15

 FINISHED 

Crimean Congo Hemorrhagic Fever; Modern Approaches to Diagnostics, Surveillance, Prevention, Therapy and Preparedness (CCH Fever)

Start date: Oct 1, 2010, End date: Mar 31, 2015,

Over the last years, large outbreaks of Crimean Congo Hemorrhagic fever virus (CCHFV) in several European countries and neighbouring areas are on the rise. This disease poses a great threat to public health due to its high mortality rate, modes of transmission and geographical distribution. Climate changes and observation of the CCHFV vector in central Europe alarm the European community as we can ...
Read Project

 18

 FINISHED 

Identification and therapeutic targeting of common arrhythmia trigger mechanisms (EUTRIGTREAT)

Start date: Oct 1, 2009, End date: Mar 31, 2015,

Arrhythmias are common manifestations of heart disease which frequently cause sudden cardiac death (SCD) or other devastating health problems. In Europe, prevention of SCD by device and drug therapy is expensive and increasingly strains public health resources due to a growing population at risk. However, identification of patients at increased risk for SCD is ineffective, and SCD prevention strat ...
Read Project

 15

 FINISHED 

Micro and Nano Engineered Bi-Directional Carbon Interfaces for Advanced Peripheral Nervous System Prosthetics and Hybrid Bionics (MERIDIAN)

Start date: Mar 1, 2012, End date: Feb 28, 2015,

The main goal of this proposal is to bring novel technology of biocompatible, low bio-fouling, high electrochemical performance carbon nanomaterials to in-vivo preclinical applications and at the same time to use this materials to develop a highly advanced concept of intimate intracellular contact, based on bottom - up technology of, engulfing the micro-electrode by neural cells. Such bionic inter ...
Read Project

 11

 FINISHED 

A novel concept for support to diagnosis and remote management of tremor (NeuroTREMOR)

Start date: Feb 1, 2012, End date: Jan 31, 2015,

Tremor is the most common movement disorder and is strongly increasing in incidence and prevalence with ageing. The most frequent types of tremor are those arising from two neurodegenerative disorders: Parkinson's disease and essential tremor. Although not life threatening, upper limb tremors hamper independent life of 65% of those suffering from them, greatly impacting on their quality of life. T ...
Read Project

 7

 FINISHED 

Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY)

Start date: Oct 1, 2009, End date: Sep 30, 2014,

"Bovine Spongiform Encephalopathy (BSE) started, 20 years ago, a devastating health and food crisis throughout Europe. Classical BSE is now under control as a result of the meat and bone meal ban. However, tonsil analyses suggest that there may be an alarmingly high number of asymptomatic PrPSc positive cases. Transmission through blood transfusion is another important concern, as are recent “atyp ...
Read Project

 21

 FINISHED 

Advanced Myoelectric Control of Prosthetic Systems (AMYO)

Start date: Sep 1, 2010, End date: Aug 31, 2014,

In spite of decades of research and many capabilities and potentials as well as incremental improvements, advanced human-maschine interfaces based on the electromyogram (EMG) still have a significant distance from professional and commercial applications. This is also and particularly true for myoelectric prosthetic devices. Available commercial myoelectric control systems for prostheses can only ...
Read Project

 6

 FINISHED 

The Interaction between the Central and Peripheral Exercise-Related Fatigue (ICPEF)

Start date: Mar 1, 2012, End date: Feb 28, 2014,

"Understanding the complex interactions between the fatigue and neuromuscular activation has been under intensive research for more than a century. Nevertheless, it remains one of the most challenging research topics in neurophysiology. The factors influencing the development of fatigue involve both peripheral (muscle) and central (spinal and supraspinal) aspects but their complex interactions are ...
Read Project

 1

 FINISHED 

Synapses: from molecules to higher brain function and diseases (SYMBAD)

Start date: Dec 1, 2009, End date: Feb 28, 2014,

SyMBaD aims to move forward our knowledge on synapse structure and function in the normal and pathological brain. Brain diseases represent a considerable social and economic burden in Europe. Emerging evidence indicates that synaptic dysfunction is associated with a majority of neurological and psychiatric disorders. Novel therapeutical approaches relie on a better knowledge of the synapse and its ...
Read Project

 13

 FINISHED 

The Synapse Nanomap (Nanomap)

Start date: Sep 1, 2008, End date: Aug 31, 2013,

Stimulated Emission Depletion (STED) microscopy is one of the most important recent developments in light microscopy (Willig et al., 2006, Nature 440:935-9). STED allows for imaging cellular elements with diffraction-unlimited resolution; in practical terms, the resolution (normally limited to ~200-300 nm) is improved down to 30-60 nm. Together with the development of two-color STED microscopy (Do ...
Read Project

 1

 FINISHED 

Public Private Partnership for Asthma Imaging and Genomics (P3AGI)

Start date: Aug 1, 2009, End date: Jul 31, 2013,

The main objective of this project is to develop a research network that includes both private and public institutions focused on the exchange of expertise in imaging, genomics and bioinformatics to be utilized in monitoring therapies and disease progression in severe allergic asthma (AA): • Aeirtec, a research-service SME with Hu-SCID in vivo models of AA that would benefit from academic expertis ...
Read Project

 5

 FINISHED 

Innate and adaptive immune responses to nanocell-based tumor-targeted cancer therapeutics (CD14)

Start date: Mar 1, 2010, End date: Feb 28, 2013,

"According to the project ‘Fighting against cancer today’ (FACT, funded by the EU 2008), molecularly targeted drugs with associated sophisticated diagnostic systems to personalize care are likely to have a great impact on cancer control in Europe. At the same time, drug delivery is going to be progressed by nanomedicines that can ferry high amounts of active drugs to the tumor. A recent achievemen ...
Read Project

 1

 FINISHED 

BNCI-driven Robotic Physical Therapies in Stroke Rehabilitation of Gait Disorders (BETTER)

Start date: Feb 1, 2010, End date: Jan 31, 2013,

Cerebral vascular accident (CVA, Stroke) is the most prevalent neurological condition leading to physical impairment in Western society. About 4.7 million stroke survivors are alive today. Impaired walking ability contributes to post-stroke walking disability. Walking incorrectly creates a stigma and makes patients more susceptible to injury, affecting quality of life. Most promising interventions ...
Read Project

 10

 FINISHED 

Lipid droplets as dynamic organelles of fat deposition and release: Translational research towards human disease (LipidomicNet)

Start date: May 1, 2008, End date: Oct 31, 2012,

Lipids are central to the regulation and control of cellular processes by acting as basic building units for biomembranes, the platforms for the vast majority of cellular functions. Recent developments in lipid mass spectrometry have set the scene for a completely new way to understand the composition of membranes, cells and tissues in space and time by allowing the precise identification and quan ...
Read Project

 27

 FINISHED 

Personalized health monitoring (PHM)- Interdisciplinary research to analyse the relationship between ethics, law and psychosocial as well as medical sciences (PHM-Ethics)

Start date: Jul 1, 2009, End date: Jun 30, 2012,

The aim of PHM-Ethics is to scientifically analyse the dependencies between ethics, law and psychosocial sciences in a dynamic part of IT development, i.e. personalized health monitoring (PHM), from a European perspective. First, the development of PHM will be reviewed to identify core steps that delineate major changes from an ethical, legal and psychosocial point of view. A taxonomy will be elab ...
Read Project

 7

 FINISHED 

Advanced gene therapy tools for treatment of CNS-specific disorders (NEUGENE)

Start date: Oct 1, 2008, End date: Mar 31, 2012,

"Curative therapies still do not exist for most CNS diseases but gene therapy is a promising new approach. We propose that it will be possible to modify brain function and pathophysiology by targeted delivery of specific curative factors to selected populations of brain cells that are affected by disease. This opens the door for effective treatment regimes, which can be tailored to individual pati ...
Read Project

 6

 FINISHED 

The Pathophysiology and Natural Course of Patients with Primary Antibody Deficiencies (PAD) (EURO-PADnet)

Start date: May 1, 2008, End date: Apr 30, 2011,

This medium-sized collaborative project will document and monitor the natural course and study the pathophysiology of Primary Antibody Deficiencies (PAD). PADs are rare inborn errors of the immune system with an estimated incidence of
Read Project

 13